Pharmaceutical composition containing 1,1,3,5-substituted biuret compound
    3.
    发明授权
    Pharmaceutical composition containing 1,1,3,5-substituted biuret compound 失效
    含有1,1,3,5-取代缩二脲化合物的药物组合物

    公开(公告)号:US4371544A

    公开(公告)日:1983-02-01

    申请号:US257418

    申请日:1981-04-24

    摘要: An analgesic, anti-inflammatory or anti-pyretic composition containing 1,1,3,5-substituted biuret compound of the formula, ##STR1## wherein R.sup.1 is a lower alkyl group or a phenyl group; R.sup.2 is a lower alkyl group, a phenyl group or a substituted phenyl group having chlorine atom(s), methyl group(s) or methoxy group(s) as the substituent(s), further R.sup.1 and R.sup.2 may form a single ring containing one or two hetero atoms including the adjacent nitrogen atom; R.sup.3 is a hydrogen atom, a lower alkyl group or a phenyl group; R.sup.4 is a phenyl group, a substituted phenyl group having halogen atom(s), trifluoromethyl group(s), methyl group(s), methoxy group(s), dimethyl-amino group(s), nitro group(s), hydroxyl group(s), acetyl group(s), or methylthio group(s) as the substituent(s), a benzyl group, a cyclohexyl group or a lower alkyl group, as the active ingredient.

    摘要翻译: 含有下式的1,1,3,5-取代缩二脲化合物的镇痛,抗炎或抗热解组合物,其中R1是低级烷基或苯基; R2是低级烷基,苯基或具有氯原子的取代苯基,甲基或甲氧基作为取代基,此外,R 1和R 2可以形成含有 一个或两个杂原子,包括相邻的氮原子; R3是氢原子,低级烷基或苯基; R4是苯基,具有卤素原子的取代苯基,三氟甲基,甲基,甲氧基,二甲基 - 氨基,硝基,羟基 基团,乙酰基或甲硫基作为取代基,苄基,环己基或低级烷基作为活性成分。

    Carbamoyl-2-pyrrolidinone compounds
    9.
    发明授权
    Carbamoyl-2-pyrrolidinone compounds 失效
    卡巴酸-2-吡咯烷酮化合物

    公开(公告)号:US5229402A

    公开(公告)日:1993-07-20

    申请号:US449923

    申请日:1989-12-13

    摘要: The present invention provides a carbamoyl-2-pyrrolidinone compound which has the following formula (2) and is useful as medicaments for treating senile dementia, i.e., as cerebral function improving agents and cerebral metabolism activators or anoxic brain damage protectives ##STR1## wherein R.sup.1 is a hydrogen atom, hydroxyl or lower alkyl substituted or unsubstituted with hydroxyl, and R.sup.3 is phenyl, tetrahydronaphthyl, pyridyl or thiazolyl having or not having lower alkoxyl, lower alkylamino, a halogen atom or halogenomethyl as a substituent.Further, the present invention provides novel carbamoyl-2-pyrrolidinone compounds represented by the formula ##STR2## wherein R.sup.1 is a hydrogen atom, hydroxyl or lower alkyl substituted or unsubstituted with hydroxyl, and R.sup.2 is phenyl, tetrahydronaphthyl, pyridyl or thiazolyl having or not having methoxy or lower alkylamino as a substituent, provided that when R.sup.1 is a hydrogen atom or unsubstituted lower alkyl, R.sup.2 is not unsubstituted phenyl.

    摘要翻译: PCT No.PCT / JP89 / 00401 Sec。 371日期1989年12月13日第 102(e)日期1989年12月13日PCT提交1989年4月12日PCT公布。 公开号WO89 / 09767 本发明提供具有下式(2)的氨基甲酰基-2-吡咯烷酮化合物,可用作治疗老年痴呆的药物,即作为脑功能改善剂和脑代谢激活剂或缺氧性脑 (2)其中R1是氢原子,羟基或被羟基取代或未取代的低级烷基,R3是具有或没有低级烷氧基,低级烷基氨基,卤原子或卤代甲基的苯基,四氢萘基,吡啶基或噻唑基 作为取代基。 此外,本发明提供由式(1)表示的新型氨基甲酰基-2-吡咯烷酮化合物,其中R 1是氢原子,羟基或被羟基取代或未取代的低级烷基,R 2是苯基,四氢萘基,吡啶基或噻唑基 具有或不具有甲氧基或低级烷基氨基作为取代基,条件是当R 1为氢原子或未取代的低级烷基时,R 2为未取代的苯基。

    Process for the preparation of glyoxal-2-oximes
    10.
    发明授权
    Process for the preparation of glyoxal-2-oximes 失效
    乙二醛2-肟的制备方法

    公开(公告)号:US4224450A

    公开(公告)日:1980-09-23

    申请号:US67888

    申请日:1979-08-20

    CPC分类号: C07D261/08

    摘要: Novel derivatives of glyoxal-2-oxim represented by the chemical formula ##STR1## wherein R is hydrogen or a lower alkyl or phenyl group, are provided in accordance with the present invention. These derivatives are prepared by reacting the corresponding isoxazole-5-carbaldehyde with nitromethane in the presence of a metal alkoxide, or the corresponding 5-acetylisoxazole with a nitrite. They have anti-inflammatory and/or analgesic activities.

    摘要翻译: 根据本发明提供了由化学式 [I]表示的乙二醛-2-肟基的新型衍生物,其中R是氢或低级烷基或苯基。 这些衍生物通过在金属醇盐或相应的5-乙酰异恶唑与亚硝酸盐存在下使相应的异恶唑-5-甲醛与硝基甲烷反应来制备。 它们具有抗炎和/或止痛活性。